Kesmalea Therapeutics
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
Operating in biotechnology, life science, medical based in Europe, Middle East, and Africa (EMEA), Kesmalea Therapeutics was founded in 2020.
The company sits in the biotechnology, life science, medical segment, where it competes on its core product or service.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Convertible_Note.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $47K.
| Sector | Biotechnology, Life Science, Medical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | convertible_note |
| Total funding | $470,000 |
Website: kesmalea.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account